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DETOXICATION STRATEGY OF EPOXIDE HYDROLASE—THE BASIS FOR
A NOVEL THRESHOLD FOR DEFINABLE GENOTOXIC CARCINOGENS
Franz Oesch, Jan Georg Hengstler, and Michael Arand 2✷ Institute of Toxicology,
University of Mainz, Mainz, Germany
2✷ From our recent work on the three-dimensional structure of epoxide hydrolases we theoretically
deduced the likelihood of a two-step catalytic mechanism that we and others have subsequently
experimentally confirmed. Analysis of the rate of the two steps by us and by others show that the
first step—responsible for removal of the reactive epoxide from the system—works extraordinarily fast
(typically three orders of magnitude faster than the second step), sucking up the epoxide like a sponge.
Regeneration of the free enzyme (the second step of the catalytic mechanism) is slow. This becomes a
toxicological problem only at doses of the epoxide that titrate the enzyme out. Our genotoxicity work
shows that indeed this generates a practical threshold below which no genotoxicity is observed. This
shows that—contrary to old dogma—practical thresholds exist for definable genotoxic carcinogens.
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INTRODUCTION
Genotoxic carcinogens are generally assumed to not show a threshold
for their effect (N.N., 1991, 1994; Purchase and Auton, 1995). This is based
on the view of genotoxic effects as stochastic, irreversible events, in contrast
to, for example, pharmacologic and toxicological effects of a drug that are
reversible, inmost cases. Receptor-mediated effects most often require amin-
imum percentage of the respective receptor molecules to be occupied, the
classical setting for a threshold, whereas the DNA alteration eventually giving
rise to a discrete step in cancer development may be the consequence of a
single hit. Thus, the chance for tumor induction decreases linearly with the
dose of the genotoxic carcinogen while the likelihood for a pharmacologic
effect decreases steeply beyond the threshold dose and rapidly approaches
zero. From this point of view, there is indeed no indication for a threshold in
carcinogenesis by genotoxic agents in contrast to the case of nongenotoxic
carcinogens for which threshold effects have been documented. However,
this simple view neglects the possibility that the concentrations of genotoxic
agents may be tightly controlled by metabolism.
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CARCINOGEN-METABOLIZING ENZYMES AS CONTROL FACTORS
OF GENOTOXICITY
There is a fair number of direct-acting mutagens/carcinogens, but most
genotoxic agents require metabolic activation (Oesch and Arand, 1999). To
allow elimination of initially lipophilic compounds via the aqueous excretion
systems of the mammalian body, a huge network of xenobiotic-metabolizing
enzymes has evolved. During biotransformation by these enzymes, some com-
pounds are “accidentally” activated to genotoxic metabolites. In the so-called
phase 1 of drugmetabolism themolecule is functionalized by introduction or
liberationof a functional group that canbeused as a handle inphase 2 of drug
metabolism to conjugate the molecule, usually with a hydrophilic endoge-
nous chemical compound (Figure 1). The resulting terminal metabolite is
generally nonreactive, nontoxic, and well soluble in water and thus easily exc-
retable. The functionalized intermediate arising from phase 1 metabolism,
however, is often chemically reactive. If the functional group that has been
introduced is electrophilic, as is the case with epoxides, it has a tendency to
react with electron-rich moieties in the DNA and give rise to DNA adducts
and/or DNA strand breaks. One example for a compound that is activated
to a genotoxic intermediate in the human body is styrene, a compound pro-
duced in thousands of tons per year. Luckily, the genotoxic intermediate, an
epoxide, is rapidly inactivated by the microsomal epoxide hydrolase (mEH;
EC 3.3.2.3), one important enzyme that protects the body from the haz-
ardous effects of many epoxides (Oesch, 1973). As will be detailed below the
FIGURE 1 The phase concept of drug metabolism.
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metabolic capacity of mEH determines a practical threshold for the genotox-
icity of compounds that are inactivated by this enzyme.
FAST DETOXIFICATION BY THE MICROSOMAL EPOXIDE
HYDROLASE DESPITE LOW TURNOVER NUMBER
Concept
mEH possesses a very broad substrate specificity. On the other hand,
the enzyme displays a comparatively low turnover number with most of its
substrates, usually smaller than 1 s¡−1 (Thomas et al., 1990). This is partly
compensated for by a very high concentration (10–50 µM, i.e., 10–50 µmol
per kg wet weight tissue, in the human liver, the prominent organ for inter-
mediate epoxide formation). However, even this is not sufficient to account
for its role as a rapid detoxifier. Recent findings have led to a detailed under-
standing of the enzymatic mechanism by which mEH and the related soluble
epoxide hydrolase hydrolyze their substrates (Lacourciere and Armstrong,
1993, 1994; Arand et al., 1994, 1996; Hammock et al., 1994; Tzeng et al., 1996,
1998; Mu¨ller et al., 1997; Laughlin et al., 1998; Arand et al., in press). These
enzymes belong to the large structural family of α/β hydrolase fold enzymes
(Ollis et al., 1992). These enzymes harbor a catalytic triad. In the first step
of the enzymatic reaction, the catalytic nucleophile, which is an aspartic acid
residue in the case of the epoxide hydrolases, attacks the substrate to form
an enzyme–substrate ester intermediate. This is subsequently hydrolyzed by
an activated water molecule. Water activation is achieved by proton abstrac-
tion through a charge-relay system composed of a histidine residue that
is hydrogen-bonded to an acidic residue, either glutamic or aspartic acid.
In the case of enzymatic epoxide hydrolysis, the first step of the reaction
proceeds significantly faster than the second step, which therefore becomes
rate-limiting.Armstrong (1999) calculated, for glycidyl-4-nitrobenzoate as the
substrate, the rate constant of step 1 to be three orders of magnitude higher
than the rate constant for step 2 (Tzeng et al., 1996). According to our own
work, similar reaction kinetics exist for the turnover of 9,10-epoxystearic acid
(Arand et al., 1999) and styrene oxide. The most important point from this
new insight in the enzymatic mechanism of mEH is to realize that the rate of
product formation does not adequately mirror the detoxification efficiency
of the enzyme. Because step 1 is much faster than step 2 of the enzymatic
reaction, the ester intermediate will accumulate at the cost of the substrate,
that is, the free epoxide. Therefore, in the initial phase of the reaction, much
more epoxide will be consumed than terminal (phase 2) product (the diol)
is formed (Figure 2). As long as the enzyme is in excess over its substrate,
which can be taken as a realistic setting under usual conditions of exposure
to toxic epoxides, the epoxide is eliminated much faster than the diol is
formed.
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FIGURE 2 Computer simulation of epoxide hydrolysis by epoxide hydrolase. In the present scenario,
an epoxide is added to a compartment containing an epoxide hydrolase. The starting concentrations
of enzyme and substrate are assumed to approximately reflect the reality with human mEH as enzyme
and styrene oxide as substrate 50 and 1 µM, respectively. Using 2 mM, 200 s¡−1, and 0.2 s¡−1 as the
values for K S, k1, and k2, the above time curves result. The major observation is that the substrate
(i.e., the epoxide) disappears rapidly while the final product, the diol, builds up comparatively slowly.
The apparent discrepancy is resolved by the fact that the covalent intermediate that is rapidly formed
represents a reservoir from which the product is gradually released by the slow, hydrolytic step of the
enzymatic epoxide hydrolysis. E = enzyme, S = substrate (epoxide), ES = Michaelis–Menten complex,
E · S = covalent enzyme–substrate intermediate, P = product (diol), K S = dissociation constant of the
Michaelis–Menten complex, k1 = rate constant of the first step (formation of the covalent intermediate),
k2 = rate constant of the second step (hydrolysis). Further details of the computation are given by Arand
et al. (2003).
This theoretical consideration can be tested in a first step by computer
simulation. As anticipated, the in silico analysis reveals a much faster decrease
in epoxide concentration compared to the increase in diol formation. Thus,
the effective dose of the genotoxic agent as represented by the area under
the time–concentration curve is actually much smaller than the calculation
from the formed diol predicts. Also important is the finding that, also under
conditions well below substrate saturation, there is an inverse proportional
relationship between epoxide steady-state concentration and epoxide hydro-
lase concentration.
Proof
A meaningful way to test the importance of a given detoxifying enzyme
in the control of a genotoxic agent is its recombinant expression in a suit-
able indicator cell line and the subsequent analysis of the susceptibility of
the recombinant cell line compared with the parental cell line toward the
genotoxic effect of the compound tested (Herrero et al., 1997). We have used
V79 Chinese hamster fibroblast cells (Doehmer et al., 1988) as the indicator
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cell line and tested the influence of recombinant mEH expression on the
styrene oxide-induced DNA strand breaks as measured by the alkaline elu-
tion technique (Herrero et al., 1997). The results show that the expression
of mEH protects V79 cells from styrene oxide-induced DNA strand break
formation up to a concentration of at least 100 µM. Above this concentra-
tion a steep rise in the genotoxic effect of the agent occurs. The parental
cell line that is essentially devoid of mEH expression shows a monophasic,
dose-dependent increase in DNA strand breaks without the initial lag phase
observed with the mEH-expressing cells. Thus, mEH expression introduces
a practical threshold for the susceptibility of V79 cells to styrene oxide geno-
toxicity. The aforementioned enzymatic mechanism is one important factor
contributing to the high clearance of styrene oxide by mEH, yet it may not
be sufficient as a stand-alone explanation for the observed threshold. In the
experiment described, the threshold concentration of 100 µM equaled a to-
tal amount of 500 nmol styrene oxide in the entire culture dish (cells plus
medium). The total amount of mEH in one dish, however, is only about
500 pmol, although the mEH concentration within a single cell is similar to
that of the epoxide, namely about 50 µM (simplified, taking the cells as the
“solvent”). Because, in this setting, there is a large substrate excess in terms of
number of substrate molecules in the entire culture dish, but in the cell there
are approximately equimolar concentrations of substrate and enzyme at the
practical threshold level, this threshold may be dominated by the cellular
concentrations of the partners, implying that the replenishment of substrate
at the site of enzyme may not be substantially faster than the regeneration
of the free enzyme. As the immunofluorescence analysis of the recombinant
cells showed, themEHwas especially highly concentrated in the endoplasmic
reticulum that surrounds the cell nucleus, the target structure of genotoxic
agents. This potentially leads to a filter effect for many lipophilic epoxides
(such as the styrene oxide) interfering with their entering the cell nucleus.
The mEH may turn the endoplasmic reticulum into a barrier that is hard
to overcome for epoxides, which eventually leads to a large difference in
epoxide concentration between the two sites separated by this barrier. The
genotoxic effect of the epoxide would become apparent once the capacity of
this barrier is exhausted.
Thus we present here an illustrative example—the detoxification of
styrene oxide by mEH—of how practical thresholds in chemical carcino-
genesis can be determined by the detoxication rate of the DNA-damaging
intermediate. A number of factors such as the enzymatic mechanism and
the subcellular compartmentalization of detoxifying enzymes synergize in
the protection of the cells against these challenges. Also, the kinetics of
processes in the activation of carcinogens may lead to nonlinearity in the
dose-response curve of such chemical carcinogens. Such practical thresh-
olds in carcinogenesis should be considered in the discussion on realistic
risks.
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